Lassa virus (LASV), a member of the Arenavirus family, remains a critical public health challenge in West Africa, with the Nigeria CDC reporting a staggering 7767
Lassa fever, a viral disease in West Africa, affects around 2 million people annually, with 5,000–10,000 deaths—but data on its true impact in high-risk groups is limited. Neonates, children, and pregnant
Last week, Safety Platform for Emergency vACcines (SPEAC) and CEPI (Coalition for Epidemic Preparedness Innovations) members participated in the 23rd annual conference of the International
The SPEAC Project updated its initial list of adverse events of special interest for mpox on 17 September. Version 1.0 is now available here. SPEAC
The SPEAC Project has developed an initial list of AESI for mpox vaccines. This list was developed by reviewing the existing vaccinia-associated AESI list and
The SPEAC Executive Board, Meta-DSMB, and Project Management Team joined CEPI’s Clinical Development Team in London in June to discuss strategy, ongoing work, and opportunities
The Safety Platform for Emergency vACcines (SPEAC) is a project funded by the Coalition for Epidemic Preparedness Innovations (CEPI). SPEAC is located at Brighton Collaboration, a program of the Task Force for Global Health.
© SPEAC 2023. All rights reserved.
